# Treating Heart Failure With hPSC-CMs

> **NCT03763136** · PHASE1,PHASE2 · COMPLETED · sponsor: **HELP Therapeutics Co., Ltd.** · enrollment: 20 (actual)

## Conditions studied

- Heart Failure

## Interventions

- **BIOLOGICAL:** hPSC-CM Therapy

## Key facts

- **NCT ID:** NCT03763136
- **Lead sponsor:** HELP Therapeutics Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-10-08
- **Primary completion:** 2024-04-30
- **Final completion:** 2024-10-30
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2025-08-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03763136

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03763136, "Treating Heart Failure With hPSC-CMs". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03763136. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*